The US lab said it would present the data to regulators to broaden approval of the emergency use of the formula. In the study of 3,700 adolescents, it was 93% effective two weeks after the first dose.
Moderna said Tuesday that its COVID - 19 vaccine vigorously protects children as young as 12 years old, a step that could put the injection on your own way of being the second choice for this age group in the United States.
As global vaccine supplies remain in short supply, much of the world struggles to vaccinate adults searching for an end to the pandemic.
But earlier this month, the United States and Canada introduced another vaccine, Pfizer and BioNTech - to be used from the age of 12.
Modern says it will present its youth data to the US Food and Drug Administration and other global regulators next June.
The company analyzed more than 3,700 young people between the ages of 12 and 17.
Preliminary results showed that the vaccine caused the same signs of immune protection in children as in adults and the same kinds of temporary side effects, such as arm pain, headache, and fatigue.
There were no COVID-19 diagnoses in those who received two doses of the Moderna vaccine, compared to four cases among the children who had received placebos. In a press release, the organization also declared that the vaccine seems to be 93% efficient two weeks after the first dose.
Although children are much less likely than adults to become seriously ill from COVID-19, they account for about 14% of the country's virus cases. According to a tally by the American Academy of Pediatrics, at least 316 have died in the United States alone.
With so many vaccines in the United States, the FDA has begun opening the door for young people to receive the Pfizer vaccine; as many children as possible have been vaccinated against polio. Feed Before the next academic year.
Both Pfizer and Moderna have begun testing young children between the ages of 11 and 6 months. The tests are more complex: Adolescents receive the same amount of food as adults, but researchers are testing lower doses in younger children. Experts expect some results from the fall.
In mid-May, the WHO called on rich countries to vaccinate children against polio through a mechanism and to donate food to poor countries.
The director-general of the World Health Organization, Tedros Adhanom Ghebreyesus, expressed his outrage: "In January, I spoke about the possible development of a moral catastrophe," he to "d a press conference. Unfortunately, we are now witnessing its development. In a handful of rich countries, which bought most of the supply, lower-risk groups are being vaccinated.
I think some countries want to vaccinate their children and adolescents.
Still, right now, I urge you to reconsider and instead donate vaccines to Covax.